# US 6,726,938 B2 · Fagopyrum cymosum (Trev.) Meisn composition, method to prepare and analyze the same and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,726,938 B2
- Document ID: US6726938B2
- Status: Granted
- Kind: B2
- Application number: 09/785,953
- Filed: 2001-02-16
- Published: 2001-08-30
- Granted: 2004-04-27
- Earliest claimed: 1997-09-29
- Inventors: Pei Han; Oiyu Guo; Bo Chen; Hongwu Zhu
- Web page: https://patentgrep.com/patent/US6726938B2

## CPC

- G01N 33/50: Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing (measuring or testing processes involving enzymes or microorganisms, compositions or test papers therefor; processes for forming such compositions, condition responsive control in microbiological or enzymological processes C12Q)
- A61K 31/70: Carbohydrates; Sugars; Derivatives thereof (sorbitol A61K31/047)
- A61P 35/00: Antineoplastic agents
- G01N 2333/415: from plants
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

This invention provides different compositions extracted from Fagopyrum cymosum (Trev.) Meisn. Said compositions comprise active components for therapeutic applications. This invention also provides a method of preparation of the compositions and a method of identification and determination of individual components of said compositions. Finally, this invention provides various uses of the compositions.

## Claims

### Claim 1

A method for treating lung cancer or alleviating clinical symptoms of lung cancer in a subject comprising administering to the subject an effective amount of the composition comprising:
a) 30-70% tannin content; and
b) 0.2-1.0% (−)epicatechin.

### Claim 2 (depends on 1)

The method of claim 1, wherein the symptom of expectoration of the subject is alleviated.

### Claim 3 (depends on 1)

The method of claim 1, wherein the symptom of chest pain of the subject is alleviated.

### Claim 4 (depends on 1)

The method of claim 1, wherein the symptom of bloody sputum of the subject is alleviated.

### Claim 5 (depends on 1)

The method of claim 1, wherein the symptom of fever of the subject is alleviated.

### Claim 6 (depends on 1)

The method of claim 1, wherein the quality of blood of the subject is improved.

### Claim 7 (depends on 1)

The method of claim 1, wherein the hemoglobin, leucocyte, or platelet count of the subject increases.

### Claim 8 (depends on 1)

The method of claim 1, wherein the daily food consumption or body weight of the subject increases.

### Claim 9 (depends on 1)

The method of claim 1, wherein the nausea or vomiting occurrence of the subject decreases.

### Claim 10 (depends on 1)

The method of claim 1 wherein diarrhea occurrence of the subject decreases.

### Claim 11 (depends on 1)

The method of claim 1 wherein debility occurrence of the subject decreases.

### Claim 12 (depends on 1)

The method of claim 1 wherein the blood sedimentation rate of the subject decreases.

### Claim 13 (depends on 1)

The method of claim 1 wherein the blood urea nitrogen of the subject decreases.

### Claim 14 (depends on 1)

The method of claim 1 wherein the Karnofsky performance scores of the subject improved.

### Claim 15 (depends on 1)

The method of claim 1 further comprising chemotherapy or radiotherapy.

### Claim 16 (depends on 15)

The method of claim 15 wherein complement C3 level of the subject increases.

### Claim 17 (depends on 15)

The method of claim 15 where E Rosette level of the subject increases.

### Claim 18 (depends on 15)

The method of claim 15 wherein the lymphocyte transforming factor, IgA, IgG, or IgM of the subject increases.

### Claim 19

A method for improving clinical signs in a subject suffering from lung cancer comprising administering to the subject an effective amount of the composition comprising:
a) 30-70% tannin content; and
b) 0.2-1% (−) epicatechin.

### Claim 20

A method for alleviating the symptom of cough in a subject suffering from common cold, bronchitis, pneumonia, pulmonary tuberculosis, pulmonary abscess, lung cancer, and upper respiratory track infection comprising administering to the subject an effective amount of the composition comprising:
a) 30-70% tannin content; and
b) 0.2-1.0% (−) epicatechin.
